GEORGINA KILFOIL

MBA, PMP – Director

Georgina has a proven track record in building, growing, and financing life-science ventures with specific expertise in strategic drug development, operational project management, and clinical plan execution.

• Executive level Life Science professional with more than 28 years of cross-functional experience in areas critical to the success of emerging and established bio-pharmaceutical companies, including: project evaluation, planning and management, strategic portfolio planning, management and integration, vendor identification and management, clinical planning and oversight
• Demonstrated effectiveness in creating operational, strategic and leadership processes essential to attaining milestones and bringing innovation to fruition.
• Most recently, was Chief Development Officer at Benitec Biopharma, a dual ASX and NASDAQ listed gene therapy company.
• Part of senior leadership team for over $500M in private and public capital debt and equity financing and for over US$1.2B in acquisitions
• Led infectious disease, cardiovascular and oncology programs, translating commercial rationales into executable global business strategies. Includes over twenty global Phase 2 and Phase 3 studies with enrolment sizes up to 6500 patients and budgets up to $100m.
• Expertise in building virtual and semi-virtual project teams to expeditiously and cost effectively move programs in a wide range of therapeutic areas through the development process from early pre-clinical to NDA filing.
• Played key roles in the development and successful NDA filings for 4 anti-infectives (Eraxis®, Doribax®, Teflaro®, Zerbaxa®) and multiple pre-NDA projects.

Georgina is a certified Project Management Professional, has a Bachelor of Science degree (Honours) in Pharmacology from the University of Bristol, United Kingdom, and a Master of Business Administration degree from the Australian Graduate School of Management, Sydney, Australia.